![(S)-3,4-Dihydro-4-hydroxy-2-(3-methoxypropyl)-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide](/ProductImageEN1/2025-03/Large/e4cdd294-7716-4fc8-b48f-91317852f574.jpg)
(S)-3,4-Dihydro-4-hydroxy-2-(3-methoxypropyl)-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide
Price | Get Latest Price | |
Package | 1kg | 25kg |
Min. Order: | 1kg |
Supply Ability: | 800kg |
Update Time: | 2025-03-12 |
Product Details
Product Name: (S)-3,4-Dihydro-4-hydroxy-2-(3-methoxypropyl)-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide | CAS No.: 154127-42-1 |
Min. Order: 1kg | Purity: 0.99 |
Supply Ability: 800kg | Release date: 2025/03/12 |
?? Brinzolamide Intermediate (CAS 154127-42-1) ??
??? Google Search Keywords:? Brinzolamide Intermediate, CAS 154127-42-1, Ophthalmic API Intermediate, Carbonic Anhydrase Inhibitor Synthesis, Pharmaceutical Intermediates
??? Product Overview?
Brinzolamide Intermediate (CAS 154127-42-1) is a high-purity chemical compound essential for synthesizing Brinzolamide, a top-tier carbonic anhydrase inhibitor used to treat glaucoma and ocular hypertension. This intermediate ensures precise and efficient production of the active pharmaceutical ingredient (API) for ophthalmic therapeutics.
?Main Function?: Critical building block in Brinzolamide API synthesis.
?Applications?: Pharmaceutical manufacturing, ophthalmic drug development, API production.
?? Key Benefits?
Purity ≥99% (HPLC) | Reduces synthesis steps by 25% | Stable under controlled storage |
Meets pharmacopeial specs | Supports cGMP and ICH guidelines |
??? Application Areas?
?Glaucoma Drug Production?: Core intermediate for Brinzolamide API.
?Ophthalmic Formulations?: Enables scalable manufacturing of eye drop solutions.
?Contract Manufacturing?: Ideal for large-scale API production.
?Generic Drug Development?: Facilitates cost-effective alternatives to branded therapies.
??? Quality Certifications?
?Testing Standards?: HPLC, GC, NMR, Mass Spectrometry.
?Compliance?: USP, EP, ICH Q7 standards.
?Packaging?: Sealed in moisture-proof containers, stored at 2-8°C.
??? Market Trends?
The global Brinzolamide market is projected to grow at ?5.2% CAGR (2024-2030)?, driven by increasing glaucoma prevalence and aging populations. Demand for high-quality intermediates surges as generic ophthalmic drugs gain FDA and EMA approvals.
Company Profile Introduction
You may like
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$0.00/1kg |
VIP1Y
|
Hebei Junhua Import and Export Co., LTD
|
2025-02-20 | |
$35.00/1kg |
Hebei Xinsheng New Material Technology Co., LTD.
|
2023-10-17 | ||
$50.00/1kg |
VIP5Y
|
Hebei Yanxi Chemical Co., Ltd.
|
2023-09-05 | |
$0.00/25kg |
PNP Biotech Co. Ltd
|
2022-10-21 | ||
$300.00/1kg |
Hebei Mingeng Biotechnology Co., Ltd
|
2022-05-05 | ||
$0.00/1KG |
Honest Joy Holdings Limited
|
2022-02-08 | ||
$0.00/1KG |
Shanghai Rlavie Technology Co ltd
|
2021-11-21 | ||
$0.00/1Kg/Bag |
VIP4Y
|
WUHAN FORTUNA CHEMICAL CO., LTD
|
2021-07-03 | |
$250.00/1KG |
Hebei Xibaijie Biotechnology Co., Ltd.
|
2020-11-03 | ||
$1.00/1KG |
VIP7Y
|
Career Henan Chemical Co
|
2018-08-09 |
- Since: 2018-06-08
- Address: Biolake.858 high-tech avenue,Wuhan
+86-+undefined-+86 13343427080
sales@biocarchem.com